Skip to main content
Premium Trial:

Request an Annual Quote

Gentris, Falco Partner to Create Japan's first GLP-Compliant PGx Lab

NEW YORK (GenomeWeb News) - Gentris has entered into an exclusive 10-year agreement with Kyoto-based Falco Biosystems to develop Japan’s first Good Laboratory Practice-compliant pharmacogenomics laboratory, Gentris announced today.
 
The partnership will be called “Gentris Japan.” Japan is the world’s second-largest pharmaceutical market after the US, Gentris said, adding drug companies in the country are increasingly looking to add pharmacogenomics into their drug-development programs.  
 
Gentris is based in Research Triangle Park, NC and provides applied clinical pharmacogenomic services and diagnostic products, the company said.
 
Financial details were not announced.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.